キャリアスクリーニング市場：タイプ別、病状別、技術別、エンドユーザー別-2024-2030年の世界予測

キャリアスクリーニング市場規模は2023年に30億7,000万米ドルと推計され、2024年には35億2,000万米ドルに達し、CAGR 14.93％で2030年には81億3,000万米ドルに達すると予測されています。

キャリアスクリーニングは、特定の遺伝性疾患の遺伝子を持っているかどうかを調べるために個人に対して行われる遺伝子検査です。遺伝子保因者である場合、一般的にその疾患の症状は現れないが、その遺伝子を子孫に受け継ぐ可能性があり、子孫はその疾患を受け継ぐリスクがあります。キャリアスクリーニングは、遺伝性疾患の家族歴のある人や、特定の遺伝性疾患の有病率が高い特定の民族グループの人に特にお勧めします。遺伝性疾患の有病率の増加、親になる可能性のある人々の意識の高まり、遺伝性疾患の負担を軽減することを目的とした政府の支援政策により、キャリアスクリーニングの採用が増加しています。しかし、遺伝子データに関連する懸念、遺伝カウンセリングの複雑さ、時折発生する偽陽性／陰性は、面倒なフォローアップ検査と差し迫った市場成長につながる可能性があります。とはいえ、一度に多数の遺伝的疾患を包括的にスクリーニングできる次世代シーケンシング（NGS）技術の統合、消費者直接遺伝子検査サービスの潜在的成長機会、さまざまな国における集団レベルでのキャリアスクリーニングプログラムの拡大は、市場成長の潜在的機会を生み出すと予想されます。

タイプExpanded キャリアスクリーニング（ECS）は遺伝子の健康状態や病態を幅広く概観できる

Expanded キャリアスクリーニング（ECS）は包括的な遺伝子検査の一形態で、様々な遺伝性疾患の保因状態を評価します。この種のスクリーニングは、希少な遺伝性疾患と一般的な遺伝性疾患の保因者を同時に同定するように設計されており、先祖や家族歴に制限されない広範な評価を提供します。ECSはしばしば、子孫に影響を及ぼす可能性のある遺伝的リスクについて、親になる見込みのある人に知らせる。カスタマイズされたパネル検査では、個人歴や家族歴、既知の保因者状態、または特定の懸念事項に基づいて、個人がスクリーニングを希望する特定の遺伝的疾患を選択することができます。このテーラーメイドのアプローチは、スクリーニングが個人の特定のニーズや嗜好に沿ったものであることを保証します。カスタム・パネルは、多様な民族的背景を持つ人々や、家系に希少な遺伝性疾患が疑われる場合に特に有益です。プレデザイン・パネル検査は、あらかじめ定義された遺伝性疾患のリストをスクリーニングする遺伝子検査です。これらのパネルは、通常、集団内の特定の疾患の有病率に基づいて、又は医学的ガイドラインに基づいて作成されます。個々人のカスタマイズを省き、遺伝の専門家が必要と判断した一連の状態に焦点を当てるため、キャリアスクリーニングにとって、よりわかりやすく、潜在的により費用対効果の高い選択肢となります。対象疾患サリアスクリーニングは、特定の遺伝性疾患の保因者であるか否かについて個人をスクリーニングする焦点を絞ったアプローチです。この種のスクリーニングは、家族内に特定の疾患のリスクがあることが知られている場合や、民族に基づくガイドラインで特定の疾患のスクリーニングが推奨されている場合に実施されることが多いです。

エンドユーザー：病院でのキャリアスクリーニングアプリケーションの進化

病院はキャリアスクリーニング市場において重要なセグメントであり、包括的なケアを提供し、幅広い専門医やサービスを利用することができます。病院は、正確な結果を得るために最新技術を取り入れたキャリアスクリーニング検査を好みます。これには次世代シーケンシング（NGS）やマイクロアレイベースのスクリーニングが含まれます。病院は、幅広い遺伝性疾患をカバーするキャリアスクリーニングを選択し、患者集団の多様なニーズに応えています。医院やクリニックは、主に外来診療に対応し、キャリアスクリーニングにより個別化されたアプローチを提供します。予算の制約から、これらの施設は基本的な品質基準を維持しながら、費用対効果の高い解決策を優先しています。大病院より専門的なスタッフを必要とする医師やクリニックは、シンプルで使いやすいキャリアスクリーニングキットを好みます。病院は、扱う症例が複雑で多岐にわたるため、最も包括的な検査パネルと高度な技術を必要とします。医院は、規模が小さく、患者との直接のやり取りが多いため、コストと使いやすさを優先します。

地域別インサイト

南北アメリカは、認知度の向上、技術の進歩、主要市場プレイヤーの存在により、キャリアスクリーニング市場が成熟しています。米国では、人口の多様な遺伝子構成とヘルスケア支出の増加により、キャリアスクリーニングに対する消費者のニーズがかなり高まっています。また、医療費負担適正化法（Affordable Care Act）は、より多くの人々がこのような検診を受けられるようにすることで、市場にプラスの影響を与えています。これらの地域では、医師の推奨や消費者向け遺伝子検査サービスの利用が顧客の購買行動に影響を与えています。主要特許には、遺伝子変異を検出するためのシークエンシング技術とバイオインフォマティクス・アルゴリズムの進歩が含まれます。欧州市場は、文化的観点、ヘルスケア政策、遺伝カウンセリングの慣行によって形成されるEU諸国間の消費者ニーズと購買行動が特徴です。スカンジナビア諸国など、ヘルスケアインフラが充実し、一人当たりの所得が高い国は、キャリアスクリーニングの採用率が高いです。ホライゾン・欧州・プログラムなどのイニシアチブがこの分野の研究とイノベーションを支援する一方、GDPRが遺伝子データ管理を法制化しています。最近では、遺伝子検査技術の強化を目的とした官民パートナーシップへの投資が見られます。中東では近親婚率が高く、遺伝性疾患の有病率が高いため、キャリアスクリーニングの需要が増加しています。中東の国々は、公衆衛生を改善するために、集団規模の遺伝子プロジェクトに投資しています。アジア太平洋地域では、ヘルスケア・インフラへの投資拡大によりキャリアスクリーニング市場が急成長しています。健康な中国2030」青写真や「ゲノム・ジャパン」プロジェクトなどの政府のイニシアチブは、ゲノム医療の推進に対する国のコミットメントを反映しています。アジア太平洋諸国は、急成長する中産階級と医療意識の高まりにより、大きなビジネスチャンスをもたらしています。アジア太平洋地域の特許は、成長する市場に対応するため、新しい遺伝子技術と費用対効果の高い検査法に焦点を当てています。全体として、この地域はキャリアスクリーニング.FPNVポジショニング・マトリックスにおける成長とイノベーションの大きな可能性を秘めています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはキャリアスクリーニング市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、キャリアスクリーニング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.キャリアスクリーニング市場の市場規模および予測は？

2.キャリアスクリーニング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.キャリアスクリーニング市場の技術動向と規制枠組みは？

4.キャリアスクリーニング市場における主要ベンダーの市場シェアは？

5.キャリアスクリーニング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患の増加と早期発見・予防への重点
    • 高齢化人口の増加と染色体異常の高リスク
    • 遺伝性疾患の管理のためのヘルスケアインフラと政府の取り組みへの投資の増加
  • 抑制要因
    • 熟練した専門家と専門サービスの不足
  • 機会
    • POC診断における新たな改善
    • キャリアスクリーニングにおける技術的進歩
  • 課題
    • 統一されていない基準やガイドラインの存在
• 市場セグメンテーション分析
  • タイプ：拡張キャリアスクリーニング（ECS）は、遺伝的健康と状態に関する幅広い概要を提供します
  • エンドユーザー：病院におけるキャリアスクリーニングの応用の進化
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 キャリアスクリーニング市場：タイプ別

• 拡張されたキャリアスクリーニング
• 対象疾患キャリアスクリーニング

第7章 キャリアスクリーニング市場病状別

• 血液疾患
• 神経疾患
• 肺疾患

第8章 キャリアスクリーニング市場：技術別

• DNA配列解析
• マイクロアレイ
• ポリメラーゼ連鎖反応

第9章 キャリアスクリーニング市場：エンドユーザー別

• 病院
• 医師のオフィスとクリニック
• リファレンスラボ

第10章 南北アメリカのキャリアスクリーニング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のキャリアスクリーニング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのキャリアスクリーニング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • インビテ、生殖医療資産のナテラへの売却を完了
  • フルジェント・ジェネティクスが新しいBeacon787拡張キャリアスクリーニングパネルを発表
  • Bio-TechneとOxford Nanopore Technologiesが提携し、革新的な生殖医療とキャリアスクリーニングソリューションを市場に投入
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CARRIER SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. CARRIER SCREENING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CARRIER SCREENING MARKET DYNAMICS
• FIGURE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARRIER SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CARRIER SCREENING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES & CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES & CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 75. CANADA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 76. CANADA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 77. CANADA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 78. CANADA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 79. CANADA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 80. CANADA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 81. CANADA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 82. CANADA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 83. CANADA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. CANADA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. MEXICO CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 86. MEXICO CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 87. MEXICO CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 88. MEXICO CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 91. MEXICO CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 92. MEXICO CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 93. MEXICO CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. MEXICO CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 98. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 101. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 102. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 103. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 104. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 105. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 106. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 110. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 116. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 119. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 120. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 121. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 122. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 124. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 125. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 126. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. CHINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 130. CHINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 131. CHINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 132. CHINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 133. CHINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 134. CHINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 135. CHINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 136. CHINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 137. CHINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. CHINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. INDIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 140. INDIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 141. INDIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 142. INDIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 143. INDIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 144. INDIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 145. INDIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 146. INDIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 147. INDIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 148. INDIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 149. INDONESIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. INDONESIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. INDONESIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 152. INDONESIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 155. INDONESIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 156. INDONESIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 157. INDONESIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 158. INDONESIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 159. JAPAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 160. JAPAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 161. JAPAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 162. JAPAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 163. JAPAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 164. JAPAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 165. JAPAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 166. JAPAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 167. JAPAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. JAPAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. MALAYSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 172. MALAYSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 173. MALAYSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 174. MALAYSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 175. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 176. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 177. MALAYSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 178. MALAYSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 179. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 180. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 181. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 182. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 183. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 184. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 185. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 186. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 187. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 188. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 189. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 190. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 191. SINGAPORE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 192. SINGAPORE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 193. SINGAPORE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 194. SINGAPORE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 195. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 196. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 197. SINGAPORE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 198. SINGAPORE CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 199. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 202. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 204. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 206. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. TAIWAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 210. TAIWAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 211. TAIWAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 212. TAIWAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 213. TAIWAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 214. TAIWAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 215. TAIWAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 216. TAIWAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 217. TAIWAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 218. TAIWAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 219. THAILAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 220. THAILAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 221. THAILAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 222. THAILAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 223. THAILAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 224. THAILAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 225. THAILAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 226. THAILAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 227. THAILAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. THAILAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. VIETNAM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 230. VIETNAM CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 231. VIETNAM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 232. VIETNAM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 233. VIETNAM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 234. VIETNAM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 235. VIETNAM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 236. VIETNAM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 237. VIETNAM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 238. VIETNAM CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 251. DENMARK CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 252. DENMARK CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 253. DENMARK CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 254. DENMARK CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 255. DENMARK CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 256. DENMARK CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 257. DENMARK CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 258. DENMARK CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 259. DENMARK CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. DENMARK CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. EGYPT CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 262. EGYPT CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 263. EGYPT CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 264. EGYPT CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 265. EGYPT CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 266. EGYPT CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 267. EGYPT CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 268. EGYPT CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 269. EGYPT CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. EGYPT CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. FINLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. FINLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. FINLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 274. FINLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 275. FINLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 276. FINLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 277. FINLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 278. FINLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 279. FINLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 280. FINLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 281. FRANCE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 282. FRANCE CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 283. FRANCE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 284. FRANCE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 285. FRANCE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 286. FRANCE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 287. FRANCE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 288. FRANCE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 289. FRANCE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 290. FRANCE CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 291. GERMANY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 292. GERMANY CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 293. GERMANY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 294. GERMANY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 295. GERMANY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 296. GERMANY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 297. GERMANY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 298. GERMANY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 299. GERMANY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 300. GERMANY CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 301. ISRAEL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 302. ISRAEL CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 303. ISRAEL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 304. ISRAEL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 305. ISRAEL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 306. ISRAEL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 307. ISRAEL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 308. ISRAEL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 309. ISRAEL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 310. ISRAEL CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 311. ITALY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 312. ITALY CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 313. ITALY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 314. ITALY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 315. ITALY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 316. ITALY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 317. ITALY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 318. ITALY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 319. ITALY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 320. ITALY CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 321. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 322. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 323. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 324. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 325. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 326. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 327. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 328. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 329. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 330. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 331. NIGERIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 332. NIGERIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 333. NIGERIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 334. NIGERIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 335. NIGERIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 336. NIGERIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 337. NIGERIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 338. NIGERIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 339. NIGERIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 340. NIGERIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 341. NORWAY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 342. NORWAY CARRIER SCREENING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 343. NORWAY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2023 (USD MILLION)
• TABLE 344. NORWAY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2024-2030 (USD MILLION)
• TABLE 345. NORWAY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2023 (USD MILLION)
• TABLE 346. NORWAY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2024-2030 (USD MILLION)
• TABLE 347. NORWAY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 348. NORWAY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 349. NORWAY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)

TABLE

[183 Pages Report] The Carrier Screening Market size was estimated at USD 3.07 billion in 2023 and expected to reach USD 3.52 billion in 2024, at a CAGR 14.93% to reach USD 8.13 billion by 2030.

Carrier screening is genetic testing conducted on individuals to determine whether they carry a gene for certain genetic disorders. As carriers, these individuals typically do not exhibit symptoms of the disorder; however, they can pass the gene on to their offspring, who may be at risk of inheriting the disease. Carrier screening is particularly recommended for individuals with a family history of genetic disorders or for those within certain ethnic groups that have a higher prevalence of specific genetic conditions. The increasing prevalence of inherited diseases, growing awareness among potential parents, and supportive government policies aimed at reducing the burden of genetic disorders increase the adoption of carrier screening. However, concerns associated with genetic data, the complexity of genetic counseling, and occasional false positives/negatives could lead to cumbersome follow-up testing and impending market growth. Nevertheless, the integration of next-generation sequencing (NGS) technologies, which allow for comprehensive screening of a large number of genetic conditions at once, the potential for growth in direct-to-consumer genetic testing services, and the expansion of carrier screening programs at the population level in various countries are expected to create potential opportunities for the market growth.

Type: Expanded carrier screening (ECS) offers a wide overview of genetic health and conditions

Expanded Carrier Screening (ECS) is a comprehensive form of genetic testing that assesses an individual's carrier status for various genetic disorders, typically including those beyond the recommendations for specific ethnicities. This type of screening is designed to simultaneously identify carriers of rare and common genetic conditions, offering a broader assessment that is not limited by ancestry or family history. ECS often informs prospective parents of potential genetic risks that could affect offspring. Customized panel testing allows individuals to select specific genetic conditions for which they wish to be screened based on personal or family history, known carrier status, or particular concerns. This tailored approach ensures that the screening aligns with the specific needs and preferences of the individual. Custom panels can be particularly beneficial for those with a diverse ethnic background or when a rare genetic disorder is suspected in the family lineage. Predesigned Panel Testing involves genetic tests that screen for a predefined list of genetic disorders. These panels are usually created based on the prevalence of certain conditions within a population or based on medical guidelines. They provide a more straightforward and potentially more cost-effective option for carrier screening, as they omit individual customization and focus on a set of conditions deemed necessary by genetic experts. Targeted disease sarrier screening is a focused approach that screens an individual for the carrier status of a specific genetic disorder. This type of screening is often performed when there is a known risk of a particular condition in a family or by ethnicity-based guidelines recommending screening for certain diseases.

End-User: Evolving application of carrier screening in hospitals

Hospitals represent a critical segment within the carrier screening market, provide comprehensive care, and have access to an expansive range of medical specialists and services. Hospitals prefer carrier screening tests incorporating the latest technologies for accurate results. This includes next-generation sequencing (NGS) and microarray-based screenings. Hospitals opt for carrier screenings that cover a wide range of genetic disorders, fulfilling the diverse needs of their patient population. Physician offices and clinics cater primarily to outpatient care and provide a more personalized approach to carrier screening. Due to budget constraints, these establishments prioritize cost-effective solutions while maintaining basic quality standards. Physicians and clinics that might need more specialized staff of larger hospitals prefer simple, easy-to-use carrier screening kits. Hospitals require the most comprehensive test panels and advanced technologies due to the complexity and variety of cases they handle. Physician offices prioritize cost and user-friendliness, given their smaller scale and more direct patient interactions.

Regional Insights

The Americas have a mature market for carrier screening, owing to heightened awareness, technological advancements, and the presence of key market players. In the United States, there is a considerable consumer need for carrier screening due to the diverse genetic makeup of the population and increasing healthcare expenditure. The Affordable Care Act has also impacted the market positively by enabling a broader population to access such screenings. Physician recommendations and the availability of direct-to-consumer genetic testing services influence customer purchasing behavior in these regions. Key patents include advances in sequencing technologies and bioinformatics algorithms for detecting genetic variants. The European market is characterized by consumer needs and purchasing behavior across EU countries, shaped by cultural perspectives, healthcare policies, and genetic counseling practices. Nations with more robust healthcare infrastructure and higher per capita income, such as the Scandinavian countries, exhibit higher adoption rates of carrier screening. Initiatives, including the Horizon Europe program, support research and innovation in the field while GDPR legislates genetic data management. Recent investments are seen in public-private partnerships aimed at enhancing genetic testing technologies. The Middle East is experiencing an increase in demand for carrier screening due to high consanguinity rates, leading to a greater prevalence of genetic disorders. Countries in the Middle East are investing in population-scale genetic projects to improve public health. In Asia-Pacific, carrier screening markets are experiencing rapid growth due to increased investment in healthcare infrastructure. Government initiatives such as the "Healthy China 2030" blueprint and the "Genome Japan" project reflect the country's commitment to advancing genomic medicine. Countries in Asia-Pacific present a vast opportunity, with a burgeoning middle class and increasing healthcare awareness. Patents in the Asia Pacific region are focusing on new genetic technologies and cost-effective testing methods to cater to the growing market. Overall, the region presents a significant potential for growth and innovation in carrier screening.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Carrier Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Carrier Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Carrier Screening Market, highlighting leading vendors and their innovative profiles. These include 23Andme Inc., Abbott Laboratories, Ambry Genetics Corporation by Konica Minolta, Inc., Asper Biogene, Autogenomics Inc. by Prescient Medicine Holdings Inc., BGI Genomics Co., Ltd., Biora Therapeutics, Inc., CENTOGENE N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Gene by Gene, Ltd. by myDNA Inc., GeneDx Holdings Corp., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, MedGenome Labs Ltd., Myriad Genetics, Inc., Natera, Inc., OPKO Health, Inc., Otogenetics Corporation, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., and TRUE HEALTH LABS.

Market Segmentation & Coverage

This research report categorizes the Carrier Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Expanded Carrier Screening
    • Customized Panel Testing
    • Predesigned Panel Testing

• Targeted Disease Carrier Screening

• Medical Condition
  • Hematological Conditions
  • Neurological Conditions
  • Pulmonary Conditions

• Technology
  • DNA Sequencing
  • Microarrays
  • Polymerase Chain Reaction

• End-User
  • Hospitals
  • Physician Offices & Clinics
  • Reference Laboratories

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Carrier Screening Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Carrier Screening Market?

3. What are the technology trends and regulatory frameworks in the Carrier Screening Market?

4. What is the market share of the leading vendors in the Carrier Screening Market?

5. Which modes and strategic moves are suitable for entering the Carrier Screening Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of inherited diseases and focus on early disease detection and prevention
    • 5.1.1.2. Rising geriatric population and high risk of chromosomal abnormalities
    • 5.1.1.3. Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Dearth of skilled professionals and professional services
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging improvements in POC diagnostics
    • 5.1.3.2. Technological advancements in carrier screening
  • 5.1.4. Challenges
    • 5.1.4.1. Presence of non-uniform standards and guidelines
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Expanded carrier screening (ECS) offers a wide overview of genetic health and conditions
  • 5.2.2. End-User: Evolving application of carrier screening in hospitals
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Carrier Screening Market, by Type

• 6.1. Introduction
• 6.2. Expanded Carrier Screening
• 6.3. Targeted Disease Carrier Screening

7. Carrier Screening Market, by Medical Condition

• 7.1. Introduction
• 7.2. Hematological Conditions
• 7.3. Neurological Conditions
• 7.4. Pulmonary Conditions

8. Carrier Screening Market, by Technology

• 8.1. Introduction
• 8.2. DNA Sequencing
• 8.3. Microarrays
• 8.4. Polymerase Chain Reaction

9. Carrier Screening Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Physician Offices & Clinics
• 9.4. Reference Laboratories

10. Americas Carrier Screening Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Carrier Screening Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Carrier Screening Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Invitae Completes Sale of Reproductive Health Assets to Natera
  • 13.3.2. Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
  • 13.3.3. Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio